Literature DB >> 1645135

Ordered appearance of human immunodeficiency virus type 1 nucleic acids following high multiplicity infection of macrophages.

J R Munis1, R S Kornbluth, J C Guatelli, D D Richman.   

Abstract

The order of appearance of human immunodeficiency virus type 1 (HIV-1) nucleic acids was examined in monocyte-derived macrophages following a high multiplicity infection with macrophage-tropic virus. Using the polymerase chain reaction, viral DNA was first detected 2 h after infection and continued to accumulate over the next 24 h. Transcripts representing tat, rev and nef splicing were detected by 24 h, and transcripts representing env splicing were detected by 48 h after infection. Coincident with the appearance of env transcripts, new synthesis of cellular and extracellular p24 antigen began, multinucleated giant cells formed and progeny infectious virus emerged. This analytical system provides a foundation for further studies on the effects of antiviral agents and cellular factors on the replication cycle of HIV-1 in non-transformed, primary monocyte-derived macrophages.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1645135     DOI: 10.1099/0022-1317-73-8-1899

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation by phorbol myristate acetate.

Authors:  T Luo; J R Downing; J V Garcia
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.

Authors:  Sachin Gupta; James M Termini; Liguo Niu; Saravana K Kanagavelu; Helena Schmidtmayerova; Victoria Snarsky; Richard S Kornbluth; Geoffrey W Stone
Journal:  J Leukoc Biol       Date:  2011-05-17       Impact factor: 4.962

3.  Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine kinase.

Authors:  T Luo; R A Livingston; J V Garcia
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Mehrnush Kalayeh; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.

Authors:  Secondo Sonza; Helen P Mutimer; Kate O'Brien; Philip Ellery; Jane L Howard; Jonathan H Axelrod; Nicholas J Deacon; Suzanne M Crowe; Damian F J Purcell
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

Authors:  C A Spina; J C Guatelli; D D Richman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo.

Authors:  D C Shugars; M S Smith; D H Glueck; P V Nantermet; F Seillier-Moiseiwitsch; R Swanstrom
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.

Authors:  S Anderson; D C Shugars; R Swanstrom; J V Garcia
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G.

Authors:  Indrapal N Singh; Robin J Goody; Celeste Dean; Nael M Ahmad; Sarah E Lutz; Pamela E Knapp; Avindra Nath; Kurt F Hauser
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.